1. Cardiac Manifestations Of Coronavirus (COVID-19)
StatPearls-/-ä 2020; ä (ä): ä
*32310612* 32310612
2. Ophthalmic Manifestations Of Coronavirus (COVID-19)
StatPearls-/-ä 2020; ä (ä): ä
*32310553* 32310553
3. Features, Evaluation and Treatment Coronavirus (COVID-19)
StatPearls-/-ä 2020; ä (ä): ä
*32150360* 32150360
4. Neuroanatomy, Nucleus Gustatory
StatPearls-/-ä 2020; ä (ä): ä
*32119409* 32119409
PMC7156237 5. Radiology Management and COVID-19 in Resource Limited Setting.
Acad Radiol 2020; 27 (5): 750
*32303440* 32303440
PMC7141462 6. Infection Control against COVID-19 in Departments of Radiology.
Acad Radiol 2020; 27 (5): 614-617
*32276755* 32276755
PMC7144862 7. CT Manifestation of COVID-19 Pneumonia; Role of Multiplanar Imaging.
Acad Radiol 2020; 27 (5): 753-754
*32276754* 32276754
PMC7136873 8. Analysis of Characteristics in Death Patients with COVID-19 Pneumonia without Underlying Diseases.
Acad Radiol 2020; 27 (5): 752
*32273135* 32273135
PMC7156158 9. Imaging Features of Coronavirus disease 2019 (COVID-19): Evaluation on Thin-Section CT.
Acad Radiol 2020; 27 (5): 609-613
*32204990* 32204990
PMC7156150 10. Coronavirus Disease (COVID-19): Spectrum of CT Findings and Temporal Progression of the Disease.
Acad Radiol 2020; 27 (5): 603-608
*32204987* 32204987
PMC7164879 11. COVID-19 Protection Guidelines in Outpatient Medical Imaging Centers.
Acad Radiol 2020; ä (ä): ä
*32336647* 32336647
PMC7164866 12. Proposed Imaging Guidelines for Pregnant Women Suspected of Having COVID-19.
Acad Radiol 2020; ä (ä): ä
*32335003* 32335003
PMC7164844 13. COVID-19 Evaluation by Low-Dose High Resolution CT Scans Protocol.
Acad Radiol 2020; ä (ä): ä
*32335002* 32335002
PMC7164893 14. Diagnosing Pulmonary Thromboembolism in COVID-19: A Stepwise Clinical and Imaging Approach.
Acad Radiol 2020; ä (ä): ä
*32331965* 32331965
PMC7158835 15. COVID-19 or Pulmonary Contusion? A Diagnostic Dilemma.
Acad Radiol 2020; ä (ä): ä
*32327295* 32327295
PMC7158787 16. COVID-19 Pulmonary Involvement: Is Really an Interstitial Pneumonia?
Acad Radiol 2020; ä (ä): ä
*32312654* 32312654
PMC7151240 17. Olfactory Bulb Magnetic Resonance Imaging in SARS-CoV-2-Induced Anosmia: The First Report.
Acad Radiol 2020; ä (ä): ä
*32295727* 32295727
PMC7102529 18. Corona Virus International Public Health Emergencies: Implications for Radiology Management.
Acad Radiol 2020; 27 (4): 463-467
*32113880* 32113880
19. Continuous Intravenous Anakinra Infusion to Calm the Cytokine Storm in Macrophage Activation Syndrome.
ACR Open Rheumatol 2020; ä (ä): ä
*32267081* 32267081
20. IV anakinra for macrophage activation syndrome may hold lessons for treatment of cytokine storm in the setting of COVID19.
ACR Open Rheumatol 2020; ä (ä): ä
*32267072* 32267072
PMC7094090 21. Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases.
ACS Cent Sci 2020; 6 (3): 315-331
*32226821* 32226821
PMC7192204 22. Updates on What ACS Reported: Emerging Evidences of COVID-19 with Nervous System Involvement.
ACS Chem Neurosci 2020; 11 (9): 1204-1205
*32343122* 32343122
PMC7179739 23. Neurological Insights of COVID-19 Pandemic.
ACS Chem Neurosci 2020; 11 (9): 1206-1209
*32320211* 32320211
PMC7160911 24. SARS-CoV-2: Olfaction, Brain Infection, and the Urgent Need for Clinical Samples Allowing Earlier Virus Detection.
ACS Chem Neurosci 2020; 11 (9): 1200-1203
*32283006* 32283006
PMC7192347 25. Is the Collapse of the Respiratory Center in the Brain Responsible for Respiratory Breakdown in COVID-19 Patients?
ACS Chem Neurosci 2020; ä (ä): ä
*32348111* 32348111
PMC7153046 26. Letter to the Editor Regarding the Viewpoint "Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanism".
ACS Chem Neurosci 2020; 11 (8): 1192-1194
*32233443* 32233443
PMC7094171 27. Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms.
ACS Chem Neurosci 2020; 11 (7): 995-998
*32167747* 32167747
PMC7098069 28. Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic Potential.
ACS Infect Dis 2020; 6 (5): 909-915
*32125140* 32125140
PMC7202248 29. Can N95 Respirators Be Reused after Disinfection? How Many Times?
ACS Nano 2020; ä (ä): ä
*32368894* 32368894
PMC7197973 30. Considering the Effects of Microbiome and Diet on SARS-CoV-2 Infection: Nanotechnology Roles.
ACS Nano 2020; ä (ä): ä
*32356654* 32356654
PMC7172500 31. Rapid Detection of COVID-19 Causative Virus (SARS-CoV-2) in Human Nasopharyngeal Swab Specimens Using Field-Effect Transistor-Based Biosensor.
ACS Nano 2020; 14 (4): 5135-5142
*32293168* 32293168
PMC7163933 32. Computational Design of ACE2-Based Peptide Inhibitors of SARS-CoV-2.
ACS Nano 2020; 14 (4): 5143-5147
*32286790* 32286790
PMC7144807 33. COVID-19: A Call for Physical Scientists and Engineers.
ACS Nano 2020; 14 (4): 3747-3754
*32267678* 32267678
PMC7123821 34. Nano Research for COVID-19.
ACS Nano 2020; 14 (4): 3719-3720
*32227916* 32227916
PMC7144809 35. Diagnosing COVID-19: The Disease and Tools for Detection.
ACS Nano 2020; 14 (4): 3822-3835
*32223179* 32223179
PMC7185834 36. Aerosol Filtration Efficiency of Common Fabrics Used in Respiratory Cloth Masks.
ACS Nano 2020; ä (ä): ä
*32329337* 32329337
PMC7158889 37. Dual-Functional Plasmonic Photothermal Biosensors for Highly Accurate Severe Acute Respiratory Syndrome Coronavirus 2 Detection.
ACS Nano 2020; ä (ä): ä
*32281785* 32281785
PMC7123907 38. Investigation into SARS-CoV-2 Resistance of Compounds in Garlic Essential Oil.
ACS Omega 2020; 5 (14): 8312-8320
*32363255* 32363255
PMC7183256 39. How Could This Happen? : Narrowing Down the Contagion of COVID-19 and Preventing Acute Respiratory Distress Syndrome (ARDS).
Acta Biotheor 2020; ä (ä): ä
*32335749* 32335749
PMC7137107 40. Visualizing an unseen enemy; mobilizing structural biology to counter COVID-19.
Acta Crystallogr D Struct Biol 2020; 76 (Pt 4): 311-312
*32254054* 32254054
PMC7137381 41. Visualizing an unseen enemy; mobilizing structural biology to counter COVID-19.
Acta Crystallogr F Struct Biol Commun 2020; 76 (Pt 4): 158-159
*32254048* 32254048
42. Cutaneous Clinico-Pathological Findings in three COVID-19-Positive Patients Observed in the Metropolitan Area of Milan, Italy.
Acta Derm Venereol 2020; ä (ä): ä
*32315073* 32315073
PMC7130453 43. Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic.
Acta Diabetol 2020; ä (ä): ä
*32249357* 32249357
44. Perspective: SARS-CoV-2, COVID-19 and Haematologists.
Acta Haematol 2020; ä (ä): 1-4
*32375142* 32375142
45. Clinical Progression of COVID-19 Patient with Extended Incubation Period, Delayed RT-PCR Time-to-positivity, and Potential Role of Chest CT-scan.
Acta Med Indones 2020; 52 (1): 80-83
*32291376* 32291376
46. The Importance of Chest CT Scan in COVID-19.
Acta Med Indones 2020; 52 (1): 68-73
*32291374* 32291374
47. Gastrointestinal Presentation in COVID-19 in Indonesia: A Case Report.
Acta Med Indones 2020; 52 (1): 63-67
*32291373* 32291373
48. Diagnosing COVID-19: Did We Miss Anything?
Acta Med Indones 2020; 52 (1): 1-4
*32291365* 32291365
PMC7197630 49. SARS-CoV-2 can induce brain and spine demyelinating lesions.
Acta Neurochir (Wien) 2020; ä (ä): ä
*32367205* 32367205
PMC7103098 50. Neurosurgery during the COVID-19 pandemic: update from Lombardy, northern Italy.
Acta Neurochir (Wien) 2020; ä (ä): ä
*32222820* 32222820
PMC7170733 51. The impact of COVID-19 on neurosurgeons and the strategy for triaging non-emergent operations: a global neurosurgery study.
Acta Neurochir (Wien) 2020; ä (ä): ä
*32314059* 32314059
PMC7156134 52. Our darkest hours (being neurosurgeons during the COVID-19 war).
Acta Neurochir (Wien) 2020; ä (ä): ä
*32291593* 32291593
53. Surgical management of head and neck tumours during the SARS-CoV (Covid-19) pandemic.
Acta Otorhinolaryngol Ital 2020; ä (ä): ä
*32271745* 32271745
PMC7102550 54. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods.
Acta Pharm Sin B 2020; ä (ä): ä
*32292689* 32292689
PMC7195321 55. Anti-RAS drugs and SARS-CoV-2 infection.
Acta Pharm Sin B 2020; ä (ä): ä
*32363137* 32363137
PMC7194921 56. Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites.
Acta Pharm Sin B 2020; ä (ä): ä
*32363136* 32363136
PMC7169934 57. D3Targets-2019-nCoV: a webserver for predicting drug targets and for multi-target and multi-site based virtual screening against COVID-19.
Acta Pharm Sin B 2020; ä (ä): ä
*32318328* 32318328
PMC7169892 58. Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19.
Acta Pharm Sin B 2020; ä (ä): ä
*32318327* 32318327
PMC7161844 59. Veno-venous extracorporeal membrane oxygenation for severe pneumonia: COVID-19 case in Japan.
Acute Med Surg 2020; 7 (1): e509
*32313662* 32313662
PMC7180652 60. Mobilization of Telepsychiatry in Response to COVID-19-Moving Toward 21(st) Century Access to Care.
Adm Policy Ment Health 2020; ä (ä): ä
*32333227* 32333227
PMC7199721 61. Need for Caution in the Diagnosis of Radiation Pneumonitis in the COVID-19 Pandemic.
Adv Radiat Oncol 2020; ä (ä): ä
*32377597* 32377597
PMC7199705 62. Experiencing the Surge: Report from a Large New York Radiation Oncology Department During the COVID-19 Pandemic.
Adv Radiat Oncol 2020; ä (ä): ä
*32377596* 32377596
PMC7165239 63. Radiation Therapy in King County, Washington During the COVID-19 Pandemic: Balancing Patient Care, Transmission Mitigation, and Resident Training.
Adv Radiat Oncol 2020; ä (ä): ä
*32313845* 32313845
PMC7118653 64. The Impact of COVID-19 on Radiation Oncology Clinics and Cancer Patients in the U.S.
Adv Radiat Oncol 2020; ä (ä): ä
*32292841* 32292841
PMC7102610 65. Running a Radiation Oncology Department at the time of coronavirus: an Italian experience.
Adv Radiat Oncol 2020; ä (ä): ä
*32292837* 32292837
PMC7142676 66. Southern Italy: How the supply of radiation therapy, patient outcomes, and risk to health care providers have changed during the COVID-19 Pandemic.
Adv Radiat Oncol 2020; ä (ä): ä
*32292843* 32292843
PMC7194647 67. Palliative Radiotherapy for Oncologic Emergencies in the setting of COVID-19: Approaches to Balancing Risks and Benefits.
Adv Radiat Oncol 2020; ä (ä): ä
*32363243* 32363243
PMC7195280 68. Efforts to Reduce the Impacts of COVID-19 Outbreak on Radiation Oncology in Taiwan.
Adv Radiat Oncol 2020; ä (ä): ä
*32363245* 32363245
PMC7186133 69. Implementation of a Novel Remote Physician SBRT Coverage Process during the Coronavirus Pandemic.
Adv Radiat Oncol 2020; ä (ä): ä
*32346656* 32346656
PMC7179507 70. Practice considerations for proton beam radiotherapy of uveal melanoma during the COVID-19 pandemic: PTCOG Ocular experience.
Adv Radiat Oncol 2020; ä (ä): ä
*32337386* 32337386
PMC7175910 71. Management of Locally Advanced Rectal Cancer During The COVID-19 Pandemic: A Necessary Paradigm Change at Memorial Sloan Kettering Cancer Center.
Adv Radiat Oncol 2020; ä (ä): ä
*32322758* 32322758
PMC7169880 72. Thoracic radiation therapy during COVID-19: provisional guidelines from a comprehensive cancer center within a pandemic epicenter.
Adv Radiat Oncol 2020; ä (ä): ä
*32318643* 32318643
PMC7194663 73. Adapting Radiation Therapy Treatments for Patients with Breast Cancer During the COVID-19 Pandemic: Hypo-Fractionation and Accelerated Partial Breast Irradiation to Address World Health Organization Recommendations.
Adv Radiat Oncol 2020; ä (ä): ä
*32363244* 32363244
PMC7165123 74. A rapid transition to voluntary breath hold from device-assisted moderate deep inspiration breath hold for patients receiving breast radiotherapy during the COVID-19 pandemic.
Adv Radiat Oncol 2020; ä (ä): ä
*32313844* 32313844
PMC7195356 75. New policy and regulation for a Radiology-Oncology Center at the time of Covid-19 outbreak in Tehran-Iran.
Adv Radiat Oncol 2020; ä (ä): ä
*32363247* 32363247
PMC7151398 76. How to reorganize the access of children in a radiotherapy department in the era of COVID19, in order to protect themselves and elderly patients.
Adv Radiat Oncol 2020; ä (ä): ä
*32292845* 32292845
PMC7195375 77. Experience of a Radiation Oncology Center Operating During the COVID-19 Outbreak.
Adv Radiat Oncol 2020; ä (ä): ä
*32363248* 32363248
PMC7118660 78. Breast radiotherapy under COVID-19 pandemic resource constraints -- approaches to defer or shorten treatment from a Comprehensive Cancer Center in the United States.
Adv Radiat Oncol 2020; ä (ä): ä
*32292842* 32292842
PMC7118610 79. Prostate Cancer Radiotherapy Recommendations in Response to COVID-19.
Adv Radiat Oncol 2020; ä (ä): ä
*32292839* 32292839
PMC7118595 80. Concerns for activated breathing control (ABC) with breast cancer in the era of COVID-19: Maximizing infection control while minimizing heart dose.
Adv Radiat Oncol 2020; ä (ä): ä
*32292838* 32292838
PMC7160610 81. The use of simulation to prepare and improve responses to infectious disease outbreaks like COVID-19: practical tips and resources from Norway, Denmark, and the UK.
Adv Simul (Lond) 2020; 5 (ä): 3
*32308988* 32308988
PMC7110984 82. Warning Against the Use of Anti-Inflammatory Medicines to Cure COVID-19: Building Castles in the Air.
Adv Ther 2020; 37 (5): 1705-1707
*32239459* 32239459
PMC7157964 83. The coronavirus pandemic and aerosols: Does COVID-19 transmit via expiratory particles?
Aerosol Sci Technol 2020; ä (ä): 1-4
*32308568* 32308568
PMC7197605 84. The Effects of a Novel Global Pandemic (COVID-19) on a Plastic Surgery Department.
Aesthet Surg J 2020; ä (ä): ä
*32347920* 32347920
PMC7128254 85. COVID-19 Severity Scoring Tool for low resourced settings.
Afr J Emerg Med 2020; ä (ä): ä
*32292690* 32292690
PMC7188182 86. Can the COVID-19 crisis strengthen our treatment escalation planning and resuscitation decision making?
Age Ageing 2020; ä (ä): ä
*32318694* 32318694
PMC7188159 87. Atypical presentation of COVID-19 in a frail older person.
Age Ageing 2020; ä (ä): ä
*32315386* 32315386
88. Preventive strategy for the clinical treatment of hip fractures in the elderly during the COVID-19 outbreak: Wuhan's experience.
Aging (Albany NY) 2020; 12 (ä): ä
*32379057* 32379057
89. Modified management mode for colorectal cancer during COVID-19 outbreak - a single-center experience.
Aging (Albany NY) 2020; 12 (ä): ä
*32379056* 32379056
90. Typical radiological progression and clinical features of patients with coronavirus disease 2019.
Aging (Albany NY) 2020; 12 (ä): ä
*32364528* 32364528
91. Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2.
Aging (Albany NY) 2020; 12 (ä): ä
*32364527* 32364527
92. Geroprotective and senoremediative strategies to reduce the comorbidity, infection rates, severity, and lethality in gerophilic and gerolavic infections.
Aging (Albany NY) 2020; 12 (8): 6492-6510
*32229705* 32229705
93. COVID-19 and chronological aging: senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection?
Aging (Albany NY) 2020; 12 (8): 6511-6517
*32229706* 32229706
94. Biomarkers of biological age as predictors of COVID-19 disease severity.
Aging (Albany NY) 2020; 12 (8): 6490-6491
*32268300* 32268300
PMC7185114 95. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis.
Aging (Albany NY) 2020; 12 (7): 6049-6057
*32267833* 32267833
96. Anti-SARS-CoV-2 virus antibody levels in convalescent plasma of six donors who have recovered from COVID-19.
Aging (Albany NY) 2020; 12 (8): 6536-6542
*32320384* 32320384
PMC7185104 97. Predictors for imaging progression on chest CT from coronavirus disease 2019 (COVID-19) patients.
Aging (Albany NY) 2020; 12 (7): 6037-6048
*32275643* 32275643
PMC7069463 98. Mesenchymal Stem Cell Infusion Shows Promise for Combating Coronavirus (COVID-19)- Induced Pneumonia.
Aging Dis 2020; 11 (2): 462-464
*32257554* 32257554
PMC7069465 99. Transplantation of ACE2(-) Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia.
Aging Dis 2020; 11 (2): 216-228
*32257537* 32257537
PMC7195611 100. Here we are: Agriculture and Human Values in the Coronavirus (COVID-19) pandemic.
Agric Human Values 2020; ä (ä): 1-2
*32362722* 32362722
PMC7186767 101. Artificial intelligence vs COVID-19: limitations, constraints and pitfalls.
AI Soc 2020; ä (ä): 1-5
*32346223* 32346223
PMC7137404 102. How Do We Balance Tensions Between COVID-19 Public Health Responses and Stigma Mitigation? Learning from HIV Research.
AIDS Behav 2020; ä (ä): ä
*32266502* 32266502
PMC7137401 103. Double Jeopardy: Methamphetamine Use and HIV as Risk Factors for COVID-19.
AIDS Behav 2020; ä (ä): ä
*32266501* 32266501
PMC7118702 104. The Impacts of Isolation Measures Against SARS-CoV-2 Infection on Sexual Health.
AIDS Behav 2020; ä (ä): ä
*32246356* 32246356
PMC7189633 105. Characterizing the Impact of COVID-19 on Men Who Have Sex with Men Across the United States in April, 2020.
AIDS Behav 2020; ä (ä): ä
*32350773* 32350773
PMC7189360 106. Development of Telemedicine Infrastructure at an LGBTQ+ Clinic to Support HIV Prevention and Care in Response to COVID-19, Providence, RI.
AIDS Behav 2020; ä (ä): ä
*32350772* 32350772
PMC7186943 107. Rapid Implementation of Service Delivery Changes to Mitigate COVID-19 and Maintain Access to Methadone Among Persons with and at High-Risk for HIV in an Opioid Treatment Program.
AIDS Behav 2020; ä (ä): ä
*32347404* 32347404
PMC7186186 108. COVID-19 Pandemic Disrupts HIV Continuum of Care and Prevention: Implications for Research and Practice Concerning Community-Based Organizations and Frontline Providers.
AIDS Behav 2020; ä (ä): ä
*32347403* 32347403
PMC7184069 109. COVID-19 Policies can Perpetuate Violence Against Transgender Communities: Insights from Peru.
AIDS Behav 2020; ä (ä): ä
*32338329* 32338329
PMC7180637 110. From HIV to Coronavirus: AIDS Service Organizations Adaptative Responses to COVID-19, Birmingham, Alabama.
AIDS Behav 2020; ä (ä): ä
*32333206* 32333206
PMC7178096 111. Physical Distancing in COVID-19 May Exacerbate Experiences of Social Isolation among People Living with HIV.
AIDS Behav 2020; ä (ä): ä
*32328849* 32328849
PMC7165075 112. The Burden of COVID-19 in People Living with HIV: A Syndemic Perspective.
AIDS Behav 2020; ä (ä): ä
*32303925* 32303925
PMC7165077 113. Research in the Time of Coronavirus: Continuing Ongoing Studies in the Midst of the COVID-19 Pandemic.
AIDS Behav 2020; ä (ä): ä
*32303924* 32303924
PMC7161803 114. Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission.
Aliment Pharmacol Ther 2020; 51 (9): 843-851
*32222988* 32222988
PMC7152511 115. Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19.
Am J Cardiovasc Drugs 2020; ä (ä): ä
*32281055* 32281055
PMC7147535 116. Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic.
Am J Clin Dermatol 2020; ä (ä): ä
*32277351* 32277351
PMC7197590 117. Association between regional selenium status and reported outcome of COVID-19 cases in China.
Am J Clin Nutr 2020; ä (ä): ä
*32342979* 32342979
PMC7188063 118. The Impact of the COVID-19 Pandemic on Cancer Patients.
Am J Clin Oncol 2020; ä (ä): ä
*32304435* 32304435
PMC7188150 119. Assessment of Specimen Pooling to Conserve SARS CoV-2 Testing Resources.
Am J Clin Pathol 2020; 153 (6): 715-718
*32304208* 32304208
PMC7184516 120. Understanding the Dynamics of COVID-19.
Am J Clin Pathol 2020; 153 (6): 850-851
*32282887* 32282887
PMC7184436 121. COVID-19 Autopsies, Oklahoma, USA.
Am J Clin Pathol 2020; 153 (6): 725-733
*32275742* 32275742
PMC7184440 122. SARS-CoV-2 Testing.
Am J Clin Pathol 2020; 153 (6): 706-708
*32227199* 32227199
PMC7184496 123. Safety Considerations in the Laboratory Testing of Specimens Suspected or Known to Contain the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Am J Clin Pathol 2020; 153 (5): 567-570
*32190890* 32190890
PMC7138186 124. Abdominal and testicular pain: An atypical presentation of COVID-19.
Am J Emerg Med 2020; ä (ä): ä
*32273141* 32273141
PMC7138187 125. Is traditional Chinese medicine useful in the treatment of COVID-19?
Am J Emerg Med 2020; ä (ä): ä
*32245701* 32245701
PMC7102516 126. Coronavirus Disease (COVID-19): A primer for emergency physicians.
Am J Emerg Med 2020; ä (ä): ä
*32265065* 32265065
PMC7141705 127. Chest CT in patients suspected of COVID-19 infection: A reliable alternative for RT-PCR.
Am J Emerg Med 2020; ä (ä): ä
*32312575* 32312575
PMC7141630 128. COVID-19 pneumonia with hemoptysis: Acute segmental pulmonary emboli associated with novel coronavirus infection.
Am J Emerg Med 2020; ä (ä): ä
*32312574* 32312574
PMC7138374 129. The effective use of telemedicine to save lives and maintain structure in a healthcare system: Current response to COVID-19.
Am J Emerg Med 2020; ä (ä): ä
*32303410* 32303410
PMC7187845 130. COVID-19 myopericarditis: It should be kept in mind in today's conditions.
Am J Emerg Med 2020; ä (ä): ä
*32360119* 32360119
PMC7169904 131. Creating a COVID-19 surge clinic to offload the emergency department.
Am J Emerg Med 2020; ä (ä): ä
*32334896* 32334896
PMC7194642 132. Social distancing during the COVID-19 pandemic: Staying home save lives.
Am J Emerg Med 2020; ä (ä): ä
*32305155* 32305155
PMC7166308 133. Cardiac injury is associated with mortality and critically ill pneumonia in COVID-19: A meta-analysis.
Am J Emerg Med 2020; ä (ä): ä
*32331955* 32331955
PMC7166306 134. Early chest computed tomography to diagnose COVID-19 from suspected patients: A multicenter retrospective study.
Am J Emerg Med 2020; ä (ä): ä
*32327245* 32327245
PMC7165082 135. Persistent hiccups as an atypical presenting complaint of COVID-19.
Am J Emerg Med 2020; ä (ä): ä
*32345563* 32345563
PMC7165122 136. The role of emergency medical services in containing COVID-19.
Am J Emerg Med 2020; ä (ä): ä
*32327247* 32327247
PMC7165114 137. iPad deployment for virtual evaluation in the emergency department during the COVID-19 pandemic.
Am J Emerg Med 2020; ä (ä): ä
*32317204* 32317204
PMC7165109 138. Cardiovascular complications in COVID-19.
Am J Emerg Med 2020; ä (ä): ä
*32317203* 32317203
PMC7162741 139. Protecting our healthcare workers during the COVID-19 pandemic.
Am J Emerg Med 2020; ä (ä): ä
*32336585* 32336585
PMC7158837 140. Pharmacotherapy in COVID-19; A narrative review for emergency providers.
Am J Emerg Med 2020; ä (ä): ä
*32336586* 32336586
PMC7156943 141. Preserving mental health and resilience in frontline healthcare workers during COVID-19.
Am J Emerg Med 2020; ä (ä): ä
*32336584* 32336584
PMC7156950 142. Redesigning emergency department operations amidst a viral pandemic.
Am J Emerg Med 2020; ä (ä): ä
*32336583* 32336583
PMC7158762 143. Areas of academic research with the impact of COVID-19.
Am J Emerg Med 2020; ä (ä): ä
*32317202* 32317202
PMC7156951 144. Adaption of the emergency department decontamination room for airway management during COVID-19.
Am J Emerg Med 2020; ä (ä): ä
*32305159* 32305159
PMC7156949 145. The use of personal protective equipment in the COVID-19 pandemic era.
Am J Emerg Med 2020; ä (ä): ä
*32305157* 32305157
PMC7151534 146. A state overview of COVID19 spread, interventions and preparedness.
Am J Emerg Med 2020; ä (ä): ä
*32334894* 32334894
PMC7151532 147. Leveraging existing quality improvement communication strategies during the COVID-19 crisis: Creation of an Emergency Department COVID-19 Case Conference.
Am J Emerg Med 2020; ä (ä): ä
*32312576* 32312576
PMC7194652 148. Strategic planning and recommendations for healthcare workers during the COVID-19 pandemic.
Am J Emerg Med 2020; ä (ä): ä
*32273142* 32273142
PMC7172492 149. Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study.
Am J Gastroenterol 2020; 115 (5): 766-773
*32287140* 32287140
PMC7172436 150. COVID-19 Disease With Positive Fecal and Negative Pharyngeal and Sputum Viral Tests.
Am J Gastroenterol 2020; 115 (5): 790
*32205644* 32205644
PMC7172490 151. Clinical Research and Trials-A "Nonessential" Victim of the COVID-19 Pandemic?
Am J Gastroenterol 2020; ä (ä): ä
*32287137* 32287137
PMC7172493 152. Digestive Symptoms in COVID-19 Patients With Mild Disease Severity: Clinical Presentation, Stool Viral RNA Testing, and Outcomes.
Am J Gastroenterol 2020; ä (ä): ä
*32301761* 32301761
PMC7172489 153. COVID-19 Presenting as Acute Hepatitis.
Am J Gastroenterol 2020; ä (ä): ä
*32301760* 32301760
PMC7175843 154. Aged Patients With Mental Disorders in the COVID-19 Era: The Experience of Northern Italy.
Am J Geriatr Psychiatry 2020; ä (ä): ä
*32360137* 32360137
155. Addressing Problems With Alcohol and Other Substances Among Older Adults During the COVID-19 Pandemic.
Am J Geriatr Psychiatry 2020; ä (ä): ä
*32359882* 32359882
PMC7195425 156. Electroconvulsive Therapy During COVID-19-Times: Our Patients Cannot Wait.
Am J Geriatr Psychiatry 2020; ä (ä): ä
*32345550* 32345550
PMC7165101 157. Anticipating and Mitigating the Impact of the COVID-19 Pandemic on Alzheimer's Disease and Related Dementias.
Am J Geriatr Psychiatry 2020; ä (ä): ä
*32331845* 32331845
PMC7162751 158. Access to Care for Dementia Patients Suffering From COVID-19.
Am J Geriatr Psychiatry 2020; ä (ä): ä
*32327300* 32327300
PMC7152884 159. Ways of Protecting Religious Older Adults from the Consequences of COVID-19.
Am J Geriatr Psychiatry 2020; ä (ä): ä
*32303403* 32303403
PMC7184512 160. Hypertension and COVID-19.
Am J Hypertens 2020; 33 (5): 373-374
*32251498* 32251498
PMC7194055 161. Rapid expansion of temporary, reliable airborne-infection isolation rooms with negative air machines for critical COVID-19 patients.
Am J Infect Control 2020; ä (ä): ä
*32371066* 32371066
PMC7141468 162. A qualitative study on the psychological experience of caregivers of COVID-19 patients.
Am J Infect Control 2020; ä (ä): ä
*32334904* 32334904
163. Weathering COVID-19 Storm: Successful Control Measures of Five Asian Countries.
Am J Infect Control 2020; ä (ä): ä
*32360746* 32360746
PMC7189852 164. Counterfeit Filtering Facepiece Respirators are posing an additional Risk to Healthcare Workers during COVID-19 Pandemic.
Am J Infect Control 2020; ä (ä): ä
*32360745* 32360745
PMC7174981 165. It's Not the Heat, It's the Humidity: Effectiveness of a Rice Cooker-Steamer for Decontamination of Cloth and Surgical Face Masks and N95 Respirators.
Am J Infect Control 2020; ä (ä): ä
*32334003* 32334003
PMC7132448 166. Several potential risks of novel coronavirus (COVID-19) pneumonia outbreaks in hospitals.
Am J Infect Control 2020; ä (ä): ä
*32291103* 32291103
PMC7162738 167. COVID-19 drive through testing: An effective strategy for conserving personal protective equipment.
Am J Infect Control 2020; ä (ä): ä
*32305432* 32305432
PMC7151256 168. Community-based prevention and control of COVID-19: Experience from China.
Am J Infect Control 2020; ä (ä): ä
*32291104* 32291104
PMC7151314 169. Seven discharged patients turning positive again for SARS-CoV-2 on quantitative RT-PCR.
Am J Infect Control 2020; ä (ä): ä
*32317126* 32317126
PMC7118604 170. COVID-19 in Hemodialysis Patients: A Report of 5 Cases.
Am J Kidney Dis 2020; ä (ä): ä
*32240718* 32240718
PMC7146661 171. COVID-19 and Dialysis Units: What Do We Know Now and What Should We Do?
Am J Kidney Dis 2020; ä (ä): ä
*32217082* 32217082
PMC7141473 172. COVID-19 and Kidney Failure in the Acute Care Setting: Our Experience From Seattle.
Am J Kidney Dis 2020; ä (ä): ä
*32276031* 32276031
PMC7130135 173. Being a Doctor Will Never Be the Same After the COVID-19 Pandemic.
Am J Med 2020; ä (ä): ä
*32240630* 32240630
PMC7191159 174. A Cured Patient With 2019-nCoV Pneumonia.
Am J Med 2020; ä (ä): ä
*32205073* 32205073
PMC7182755 175. Respiratory Muscle Performance Screening for Infectious Disease Management Following COVID-19: A Highly Pressurized Situation.
Am J Med 2020; ä (ä): ä
*32343947* 32343947
PMC7182745 176. Inpatient Care of Patients with COVID-19: A Guide for Hospitalists.
Am J Med 2020; ä (ä): ä
*32339477* 32339477
PMC7172844 177. Applications of 3D Printing Technology to Address COVID-19 Related Supply Shortages.
Am J Med 2020; ä (ä): ä
*32330492* 32330492
PMC7167564 178. An Atypical Presentation of Novel Coronavirus Disease 2019 (COVID-19).
Am J Med 2020; ä (ä): ä
*32320693* 32320693
PMC7179524 179. Coronavirus Disease 19 Infection Does Not Result in Acute Kidney Injury: An Analysis of 116 Hospitalized Patients from Wuhan, China.
Am J Nephrol 2020; ä (ä): 1-6
*32229732* 32229732
PMC7179539 180. A Case of Novel Coronavirus Disease 19 in a Chronic Hemodialysis Patient Presenting with Gastroenteritis and Developing Severe Pulmonary Disease.
Am J Nephrol 2020; ä (ä): 1-6
*32222713* 32222713
PMC7093856 181. Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know.
Am J Obstet Gynecol 2020; 222 (5): 415-426
*32105680* 32105680
PMC7194667 182. COVID-19 Pandemic: Staged Management of Surgical Services for Gynecology and Obstetrics.
Am J Obstet Gynecol 2020; ä (ä): ä
*32251649* 32251649
PMC7194742 183. The Diagnosis of Pneumonia in a Pregnant Woman with COVID-19 Using Maternal Lung Ultrasound.
Am J Obstet Gynecol 2020; ä (ä): ä
*32360111* 32360111
PMC7187838 184. Maternal Death Due to COVID-19 Disease.
Am J Obstet Gynecol 2020; ä (ä): ä
*32360108* 32360108
PMC7195009 185. Maternal Deaths with Covid19: a different outcome from mid to low resource countries?
Am J Obstet Gynecol 2020; ä (ä): ä
*32348744* 32348744
PMC7194835 186. Screening all pregnant women admitted to Labor and Delivery for the virus responsible for COVID-19.
Am J Obstet Gynecol 2020; ä (ä): ä
*32348743* 32348743
PMC7194606 187. Fetal Interventions in the Setting of COVID-19 Pandemic: Statement from the North American Fetal Therapy Network (NAFTNet).
Am J Obstet Gynecol 2020; ä (ä): ä
*32348742* 32348742
PMC7177142 188. Coronavirus disease 2019 (COVID-19) in pregnant women: A report based on 116 cases.
Am J Obstet Gynecol 2020; ä (ä): ä
*32335053* 32335053
PMC7175884 189. COVID-19 in Pregnancy: Consider Thromboembolic Disorders and Thromboprophylaxis.
Am J Obstet Gynecol 2020; ä (ä): ä
*32333857* 32333857
PMC7165087 190. COVID19 during pregnancy: a systematic review of reported cases.
Am J Obstet Gynecol 2020; ä (ä): ä
*32311350* 32311350
PMC7158836 191. Pregnant versus non-pregnant SARS-CoV-2 and COVID-19 Hospital Admissions: The first 4 weeks in New York.
Am J Obstet Gynecol 2020; ä (ä): ä
*32304691* 32304691
PMC7151436 192. Care of the Pregnant Woman with COVID-19 in Labor and Delivery: Anesthesia, Emergency cesarean delivery, Differential diagnosis in the acutely ill parturient, Care of the newborn, and Protection of the healthcare personnel.
Am J Obstet Gynecol 2020; ä (ä): ä
*32283073* 32283073
PMC7104131 193. Outcome of Coronavirus spectrum infections (SARS, MERS, COVID 1 -19) during pregnancy: a systematic review and meta-analysis.
Am J Obstet Gynecol MFM 2020; ä (ä): 100107
*32292902* 32292902
PMC7195418 194. MFM guidance for COVID-19.
Am J Obstet Gynecol MFM 2020; ä (ä): 100106
*32363335* 32363335
PMC7144599 195. COVID-19 infection among asymptomatic and symptomatic pregnant women: Two weeks of confirmed presentations to an affiliated pair of New York City hospitals.
Am J Obstet Gynecol MFM 2020; ä (ä): 100118
*32292903* 32292903
PMC7194868 196. Two cases of coronavirus 2019-related cardiomyopathy in pregnancy.
Am J Obstet Gynecol MFM 2020; ä (ä): 100113
*32363336* 32363336
PMC7187860 197. False-Negative COVID-19 Testing: Considerations in Obstetrical Care.
Am J Obstet Gynecol MFM 2020; ä (ä): 100130
*32346672* 32346672
PMC7182514 198. Forecasting the Impact of Coronavirus Disease During Delivery Hospitalization: An Aid for Resources Utilization.
Am J Obstet Gynecol MFM 2020; ä (ä): 100127
*32342041* 32342041
PMC7194528 199. Severe ARDS in COVID-19-infected pregnancy: obstetric and intensive care considerations.
Am J Obstet Gynecol MFM 2020; ä (ä): 100120
*32363337* 32363337
200. Virtual Ophthalmology: Telemedicine in a Covid-19 Era.
Am J Ophthalmol 2020; ä (ä): ä
*32360862* 32360862
PMC7201238 201. Haemorrhagic conjunctivitis with pseudomembranous related to SARS-CoV-2.
Am J Ophthalmol Case Rep 2020; ä (ä): 100735
*32377594* 32377594
PMC7128762 202. Smartphone-enabled wireless otoscope-assisted online telemedicine during the COVID-19 outbreak.
Am J Otolaryngol 2020; ä (ä): 102476
*32305252* 32305252
PMC7128936 203. Upper airway symptoms in coronavirus disease 2019 (COVID-19).
Am J Otolaryngol 2020; ä (ä): 102474
*32278470* 32278470
PMC7195080 204. Otolaryngology during COVID-19: Preventive care and precautionary measures.
Am J Otolaryngol 2020; ä (ä): 102508
*32345446* 32345446
PMC7132500 205. Hearing loss and COVID-19: A note.
Am J Otolaryngol 2020; ä (ä): 102473
*32276732* 32276732
PMC7166300 206. COVID-19 and hearing difficulties.
Am J Otolaryngol 2020; ä (ä): 102496
*32327217* 32327217
207. Cohesion in Distancing.
AMA J Ethics 2020; 22 (4): E344-345
*32345430* 32345430
208. Primer caso de infeccion neonatal por SARS-CoV-2 en Espana.
An Pediatr (Barc) 2020; 92 (4): 237-238
*32245738* 32245738
